Maureen Gebben
Papers
1
Total Citations
20
H-Index
1
About
Dr. Maureen Gebben is a clinical researcher whose work centers on the early detection and prediction of acute kidney injury (AKI), particularly in the context of urological surgery. Her most cited study, "Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study" (2018, 20 citations), represents a significant contribution to nephrology and surgical oncology. In this feasibility study, Dr. Gebben investigated the potential of novel urinary biomarkers to identify AKI before standard clinical indicators appear, aiming to improve postoperative outcomes for patients undergoing partial nephrectomy. By focusing on this critical window for intervention, her research addresses a pressing clinical need to reduce the incidence and severity of kidney damage after surgery. Though her citation count reflects a focused, emerging body of work, Dr. Gebben’s findings have implications for refining risk stratification and guiding perioperative care. Her dedication to translational research—bridging biomarker discovery with practical surgical applications—positions her as a promising voice in the effort to make kidney-sparing surgeries safer and more predictable.
Research Focus
Key Achievements
Top Papers
- 1